Abstract:Abstract Neurodegenerative diseases are progressive neurological disorders with selective neuron loss in particular regions of brain, including frontotemporal lobar degeneration (FTLD), Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD), and many others. Gene defects have been recognized as a prominent factor in the etiology and pathogenesis of neurodegenerative diseases. To date, hundreds of genetic variants that located in dozens of genes have been associated with susceptibility to various neurodegenerative diseases. Among them, more than 60 mutations in progranulin (PGRN) have been reported in FTLD, AD, ALS and PD. One of the mutations in PGRN gene exon 1 introduces a charged amino acid in the hydrophobic core of the signal peptide at residue 9 (PGRN A9D), and results in cytoplasmic mis-sorting of this protein. However, the mechanism of actions of this mis-sorting remains elusive. To address this issue, we first examined the subcellular distribution of PGRN with A9D mutation in human neuronal-like cells (SH-SY5Y). The results have shown that PGRN A9D mutation failed to undergo maturation and accumulated in the stress granules. Interestingly, this mutation also induces redistribution of cellular angiogenin (ANG), a stress response factor and neurodegenerative diseases related protein, from nuclear to cytoplasm. PGRN was also directly interacted with ANG in stress granules. Furthermore, the cytoplasmic retardation of ANG by PGRN A9D mutation abolished ANG-enhanced rRNA transcription and cell survival. Taken together, these results indicate that PGRN with A9D mutation changed localization of ANG as well as cell growth and survival, suggesting that PGRN and ANG act in concert to regulate the progress of neurodegenerative diseases. Citation Format: Jinghao Sheng, Yongdui Chen, Siqi Li, Haojie Dong, Guangdi Chen, Zhengping Xu. Progranulin A9D mutation functionally leads to the cytoplasm retardation of angiogenin. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 1559. doi:10.1158/1538-7445.AM2015-1559

The <i>FAM171A2</i> gene is a key regulator of progranulin expression and modifies the risk of multiple neurodegenerative diseases

The FAM171A2 gene is a key regulator of progranulin expression and modifies the risk of multiple neurodegenerative diseases

Pathogenic cysteine mutations affect progranulin function and production of mature granulins.

Progranulin as a therapeutic target in neurodegenerative diseases

Elevated Progranulin Contributes to Synaptic and Learning Deficit Due to Loss of Fragile X Mental Retardation Protein.

Progranulin Protects Against Amyloid Β Deposition and Toxicity in Alzheimer’s Disease Mouse Models

Microglial Progranulin: Involvement in Alzheimer’s Disease and Neurodegenerative Diseases

GRN Missense Variants and Familial Alzheimer's Disease: Two Case Reports

The Role of Pgrn in Alzheimer'S Disease

Association of progranulin polymorphism rs5848 with neurodegenerative diseases: a meta-analysis

GRN deletion in familial frontotemporal dementia showing association with clinical variability in 3 familial cases

Progranulin polymorphism rs5848 is associated with increased risk of Alzheimer's disease.

Disease and Region Specificity of Granulin Immunopositivities in Alzheimer Disease and Frontotemporal Lobar Degeneration.

Exaggerated Inflammation, Impaired Host Defense, and Neuropathology in Progranulin-Deficient Mice

PGRN Is Associated with Late-Onset Alzheimer’s Disease: a Case–Control Replication Study and Meta-analysis

Progranulin mutations as risk factors for Alzheimer disease

Progranulin Does Not Bind Tumor Necrosis Factor (TNF) Receptors and is Not a Direct Regulator of TNF-Dependent Signaling or Bioactivity in Immune or Neuronal Cells

Losing protein in the brain: the case of progranulin

An Alternative In Vitro Model Of Neurodegeneration In Ftld-U With Pgrn Mutation

Abstract 1559: Progranulin A9D Mutation Functionally Leads to the Cytoplasm Retardation of Angiogenin

A systematic review of progranulin concentrations in biofluids in over 7,000 people—assessing the pathogenicity of GRN mutations and other influencing factors